Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             23 results found
no title author magazine year volume issue page(s) type
1 Clinical research on rare diseases of children: neuroblastoma Gerardi, Chiara
2016
79 2 p. 267-273
article
2 Comment to: GSTP1, GSTM1 and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis Cargnin, Sarah
2017
79 2 p. 435-436
article
3 Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205 Zhang, Hong-Yan
2017
79 2 p. 327-337
article
4 Ionotropic glutamate receptor antagonists and cancer therapy: time to think out of the box? Ribeiro, Mariana P. C.
2016
79 2 p. 219-225
article
5 Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues Mayo, Bronwen J.
2016
79 2 p. 233-249
article
6 Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect? Cohen, Ian Joseph
2017
79 2 p. 437
article
7 Modulation of cyclophosphamide-induced cardiotoxicity by methyl palmitate El-Agamy, Dina S.
2017
79 2 p. 399-409
article
8 Molecular explorations of substituted 2-(4-phenylquinolin-2-yl) phenols as phosphoinositide 3-kinase inhibitors and anticancer agents Alagumuthu, Manikandan
2017
79 2 p. 389-397
article
9 Myeloprotective effects of C-type natriuretic peptide on cisplatin-induced bone marrow granulocytopenia in mice Zenitani, Masahiro
2017
79 2 p. 363-368
article
10 On-treatment markers as predictors to guide anti-EGFR MoAb treatment in metastatic colorectal cancer: a systematic review with meta-analysis Hu, Jing
2016
79 2 p. 275-285
article
11 Pharmacokinetic and exposure–response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancer Quartino, Angelica L.
2017
79 2 p. 353-361
article
12 Pharmacology and toxicology of the novel investigational agent Cantrixil (TRX-E-002-1) Saif, Muhammad Wasif
2016
79 2 p. 303-314
article
13 Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC) Abou-Alfa, Ghassan K.
2017
79 2 p. 421-429
article
14 Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report Coller, Janet K.
2016
79 2 p. 431-434
article
15 Reduced proliferation and colony formation of head and neck squamous cell carcinoma (HNSCC) after dual targeting of EGFR and hedgehog pathways Liebig, Hannes
2017
79 2 p. 411-420
article
16 Research progress of hydroxychloroquine and autophagy inhibitors on cancer Shi, Ting-Ting
2016
79 2 p. 287-294
article
17 Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study Sarantopoulos, John
2017
79 2 p. 339-351
article
18 Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer Tabchi, Samer
2017
79 2 p. 381-387
article
19 The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer Zang, Hongjing
2016
79 2 p. 227-231
article
20 The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy Chen, Jianli
2017
79 2 p. 369-380
article
21 Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors Ajorlou, Elham
2016
79 2 p. 251-265
article
22 Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer Infante, Jeffrey R.
2017
79 2 p. 315-326
article
23 Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells Moreb, Jan S.
2016
79 2 p. 295-301
article
                             23 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands